바이오리액터 및 발효조 시장 : 제품 유형별, 제조 재료별, 바이오프로세스 유형별, 생물제제 유형별, 주요 지역별

Bioreactors and Fermenters Market Distribution by Type of Product, Fabrication Material, Type of Bioprocess, Type of Biologic and Key Geographical Regions

US $ 4,799 ￦ 6,655,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,999 ￦ 9,706,000

PDF (One-Location Site License)

PDF 보고서를 동일 사업장의 특정 사업 부문에 속한 모든 분들이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,599 ￦ 14,698,000

PDF (Department License)

PDF 보고서를 부서 단위로 12명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 17,999 ￦ 24,961,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계 바이오리액터 및 발효조 시장 규모는 2035년까지 예측 기간 동안 11.1%의 연평균 복합 성장률(CAGR)로, 232억 달러에서 2035년까지 739억 달러로 성장할 것으로 예측됩니다.

이 시장 세분화는 시장 규모와 기회 분석을 다음 매개 변수로 구분합니다.

제품 유형별

• 바이오리액터
• 발효조

제조 재료별

• 유리
• 스테인리스
• 일회용

바이오프로세스 유형별/p>

• 배치 및 페드 배치
• 연속

생물제제 유형별

• 항체
• 백신
• 세포 치료제
• 기타

주요 지역

• 북미
• 유럽
• 아시아태평양
• 중동 및 북아프리카
• 라틴아메리카

바이오리액터 및 발효조 시장 : 성장과 동향

바이오리액터 및 발효조는 재조합 단백질, 조직 공학적 구조물, 시험관내 세포 기반 모델과 같은 고가치 제품을 생산하는 데 필요한 조건을 제공함으로써 생물 생산의 업스트림에서 필수적인 역할을 합니다. 바이오리액터에 의한 세포 배양 기술은 20세기 초에 개발되었습니다. 이러한 장비의 사용과 확장성은 새로운 생물학적 제품에 대한 수요가 증가함에 따라 발전해 왔습니다. 실제로 백신, 융합 단백질, 항체, 호르몬, 인터루킨, 인터페론, 효소, 첨단 치료제(ATMP) 등 다양한 치료에 대한 수요 증가에 대응하기 위해 바이오제약회사, CMO, 비업계 기업은 바이오리액터에 엄청난 투자를 해왔습니다.

생물반응기와는 대조적으로, 발효기는 미생물(진균 또는 박테리아) 세포 집단의 혐기성 배양에 사용되며 번역 후 상당한 변형을 필요로 하지 않는 생물학적 제형을 생산합니다. 바이오 의약품 시장, 특히 COVID-19 팬데믹 이후의 전반적인 성장은 바이오 리액터를 포함한 고급 업스트림 바이오프로세스 기술에 대한 수요 상승으로 이어져 장비 제조업체에 유리한 기회를 제공합니다.

바이오리액터 및 발효조 시장 : 주요 인사이트력

이 보고서는 바이오 리액터 및 발효기 시장의 현재 상태를 파악하고 업계 내 잠재적 성장 기회를 확인합니다. 주요 조사 결과는 다음과 같습니다.

• 현재 255개가 넘는 기업이 세계 다양한 유형의 생물반응기 및 발효조를 생산하는 데 필요한 전문 지식을 보유하고 있습니다.
• 현재 시장 상황은 다양한 용량 범위와 조작 모드의 바이오리액터 및 발효조의 제조에 종사하는 기존 기업과 신흥 기업 모두의 존재를 특징으로 하고 있습니다.
• 기업의 80% 가까이, 배치 프로세스용의 바이오리액터 및 발효조를 제조하고 있어, 이 중 55%의 제조업체는 실험실 규모로부터 상업 규모에 장치를 스케일 업하는 능력을 가지고 있습니다.

• 바이오리액터 및 발효조 시장 환경은 단편화되어 있어 기존 기업의 대부분은 신흥국 시장에 소재하고 있지만, 소규모 기업의 대부분은 아시아태평양에 소재하고 있습니다.
• 복잡한 생물제제에 대한 수요 증가에 의해 신규의 바이오리액터 및 발효조에 대한 요구가 높아지고 있어 바이오리액터 및 발효조 제조업체는 그 능력을 업그레이드하도록 요구되고 있습니다.
• 세계의 바이오 리액터 및 발효조의 설치 능력은 다양한 지역에 분산되어 있어, 이 능력의 60% 이상은 생물 제제 제조업체의 사내 시설에 설치되어 있습니다.
• 스테인레스 스틸 바이오 리액터는 현재 설치된 생물 제제 제조 능력 중에서 큰 점유율을 차지하고 있으며, 이 점유율의 대부분은 포유류 및 미생물 기반 치료제의 제조에 사용되고 있습니다.
• 바이오리액터 및 발효조 세계 시장은 2035년까지 연평균 복합 성장률(CAGR) 11.1%로 성장할 것으로 보입니다.
• 장기적으로는 항체 및 기타 신규 생물 제제의 제조에 사용되는 일회용/단일 유스 시스템이 시장 전체의 주요 성장 요인으로 부상할 가능성이 높습니다.

바이오리액터 및 발효조 시장 : 주요 부문

제품 유형별로 시장은 바이오리액터 및 발효조로 구분됩니다. 현재 바이오리액터 부문이 세계 바이오리액터 및 발효조 시장에서 최대 점유율을 차지하고 있습니다.

제조 재료별로 시장은 유리, 스테인레스 스틸, 일회용 바이오 리액터로 구분됩니다. 리액터의 바이오리액터 및 발효조 시장은 에너지와 물의 총 소비량을 -50% 삭감하고 배치 생산마다 세정 및 멸균 공정을 생략함으로써 -40%의 비용 절감을 실현하는 등 몇 가지 이점이 있기 때문에 상대적으로 높은 CAGR로 성장할 가능성이 높습니다.

바이오프로세스 유형별로는 시장은 배치식과 페드배치식, 연속식으로 구분됩니다.

생물 제형 유형별로 세계 시장은 항체, 백신, 세포 요법 및 기타 생물 제제로 구분됩니다. 현재 항체 분야가 가장 큰 시장 점유율을 차지하고 있습니다.

주요 지역별로 볼 때 시장은 북미, 유럽, 아시아태평양, 중동, 북아프리카, 라틴아메리카로 구분됩니다.

본 보고서에서는 세계의 바이오리액터 및 발효조 시장에 대해 조사했으며, 시장 개요와 함께 제품 유형별, 제조 재료별, 바이오프로세스 유형별, 생물제제 유형별, 주요 지역별 동향, 시장 진출기업프로파일 등의 정보를 제공합니다.

목차

제1장 서문

제2장 주요 요약

제3장 소개

제4장 바이오리액터 및 발효조 제조업체 : 시장 상황

• 장의 개요
• 바이오리액터 및 발효조 제조업체 : 시장 상황

제5장 기업 경쟁력 분석

• 장의 개요
• 전제/주요 파라미터
• 조사 방법
• 기업 경쟁력 분석 : 중소기업
• 기업 경쟁력 분석 : 중규모 기업
• 기업 경쟁력 분석 : 대기업과 초대 기업

제6장 기업 프로파일

• 장의 개요
• Applikon Biotechnology(Getinge 인수)
• Bionet
• Cytiva
• Eppendorf
• Merck
• Ollital Technology
• Parr Instrument Company
• Sartorius
• Shanghai Bailun Biological Technology
• Solaris Biotech(Donaldson Company 인수)
• Solida Biotech
• Zhengzhou Laboao Instrument Equipment(LABAO)

제7장 용량 분석

• 장의 개요
• 주요 전제와 조사 방법
• 결론

제8장 사례 연구: 바이오프로세스 컨트롤러 및 자동화 시스템

제9장 시장 예측

• 장의 개요
• 주요 전제와 예측 조사 방법
• 세계의 바이오리액터 및 발효조 시장(-2035년)

제10장 주요 인사이트

제11장 결론

제12장 부록 1: 표 형식 데이터

제13장 부록 2 : 기업 및 단체 일람

SHW

영문 목차

영문목차

BIOREACTORS AND FERMENTERS MARKET: OVERVIEW

As per Roots Analysis, the global bioreactors and fermenters market is estimated to grow from USD 23.2 billion in the current year to USD 73.9 billion by 2035, at a CAGR of 11.1% during the forecast period, till 2035.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Product

• Bioreactors
• Fermenters

Fabrication Material

• Glass
• Stainless Steel
• Single Use

Type of Bioprocess

• Batch and Fed-batch
• Continuous

Type of Biologic

• Antibodies
• Vaccines
• Cell Therapies
• Other Biologics

Key Geographical Regions

• North America
• Europe
• Asia-Pacific
• Middle East and North Africa
• Latin America

BIOREACTORS AND FERMENTERS MARKET: GROWTH AND TRENDS

Bioreactors and fermenters play an indispensable role in upstream biomanufacturing by providing the requisite conditions for producing high-value products, including recombinant proteins, tissue- engineered constructs and in vitro cell-based models. The technique of culturing cells via bioreactors was developed in the early twentieth century. The usage and scalability of such instruments evolved with the ever-increasing demand for novel biological products. In fact, biopharma companies, CMOs, and non-industry players have significantly invested in bioreactors to meet the rising demand for various therapies, including vaccines, fusion proteins, antibodies, hormones, interleukins, interferons, enzymes, and advanced therapeutic medicinal products (ATMPs).

In contrast to bioreactors, fermenters are used for the anaerobic cultivation of microbial (fungal or bacterial) cell populations to produce biologics that do not require significant post-translational modifications. The overall growth of the biopharmaceutical market, specifically post the COVID-19 pandemic, has led to a rise in demand for advanced upstream bioprocessing technologies, including bioreactors, offering lucrative opportunities to equipment manufacturers.

BIOREACTORS AND FERMENTERS MARKET: KEY INSIGHTS

The report delves into the current state of the bioreactors and fermenters market and identifies potential growth opportunities within the industry. Some key findings from the report include:

• Presently, over 255 companies have the required expertise to manufacture various types of bioreactors and fermenters across the globe.
• The current market landscape features the presence of both established and emerging players engaged in the manufacturing of bioreactors and fermenters of variable capacity ranges and modes of operation.
• Close to 80% of firms manufacture bioreactors and fermenters for batch processes; of these, 55% of the manufacturers have the capability to scale up their equipment from lab to commercial scale.

• The bioreactors and fermenters market landscape is fragmented; most of the well-established players are located in developed regions, while majority of small players are located in the Asia-Pacific region.
• Owing to the rise in demand for complex biologics, the requirement of novel bioreactors and fermenters is increasing, which has prompted the bioreactor and fermenter manufacturers to upgrade their capabilities.
• The global installed bioreactors and fermenters capacity is distributed across various geographies; over 60% of this capacity is installed in the in-house facilities of biologics manufacturers.
• Stainless steel bioreactors hold a prominent share of the current installed biomanufacturing capacity; the majority of this share is dedicated to the manufacturing of mammalian and microbial-based therapeutics.
• The global bioreactors and fermenters market is likely to grow at a CAGR of 11.1%, till 2035; the projected opportunity is likely to be driven by continuous manufacturing bioprocesses.
• In the long term, the disposable / single-use systems used for the manufacturing of antibodies and other novel biologics will likely emerge as the key growth drivers of the overall market.

BIOREACTORS AND FERMENTERS MARKET: KEY SEGMENTS

Bioreactors Segment Occupy the Largest Share of the Bioreactors and Fermenters Market

Based on the type of product, the market is segmented into bioreactors and fermenters. At present, the bioreactors segment holds the maximum share of the global bioreactors and fermenters market. Additionally, the fermenters segment is likely to grow at a faster pace during the forecasted period.

By Fabrication Material, Single Use Bioreactors is the Fastest Growing Segment of the Global Bioreactors and Fermenters Market

Based on the fabrication material, the market is segmented into glass, stainless steel and single use bioreactors. Currently, the stainless-steel bioreactors segment captures the highest proportion of the global bioreactors and fermenters market. Further, the bioreactors and fermenters market for single use bioreactors is likely to grow at a relatively higher CAGR owing to its several benefits, such as ~50% reduction in total energy and water consumption and ~40% cost saving by elimination of cleaning and sterilization processes after every batch production.

Batch and Fed-Batch Segment Occupy the Largest Share of the Bioreactors and Fermenters Market by Type of Bioprocess

Based on the type of bioprocess, the market is segmented into batch and fed batch, and continuous. At present, bioreactors used in batch and fed-batch mode hold the maximum share of the bioreactors and fermenters market. Further, it is worth highlighting that the bioreactors and fermenters market for the continuous type of bioprocess segment is likely to grow at a relatively higher CAGR.

Currently, the Antibodies Segment Holds the Largest Share of the Bioreactors and Fermenters Market

Based on the type of biologic, the global market is segmented into antibodies, vaccines, cell therapies and other biologics. Currently, the antibodies segment holds the largest market share. However, the bioreactors and fermenters market for vaccines segment is expected to witness substantial growth in the coming years.

Europe Accounts for the Largest Share of the Market

Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America. Currently, Europe dominates the global bioreactors and fermenters market and accounts for the largest revenue share. Further, the market in Europe is expected to grow at a higher CAGR in the coming years.

Example Players in the Bioreactors and Fermenters Market

• Applikon Biotechnology
• Bionet
• Cytiva
• Eppendorf
• Merck
• Ollital Technology
• Parr Instrument Company
• Sartorius
• Shanghai Bailun Biological Technology
• Solaris Biotech
• Solida Biotech
• Zhengzhou Laboao Instrument Equipment (LABAO)

BIOREACTORS AND FERMENTERS MARKET: RESEARCH COVERAGE

• Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the global bioreactors and fermenters market, focusing on key market segments, including [A] type of product, [B] fabrication material, [C] type of bioprocess, [D] type of biologic and [E] key geographical regions.
• Market Landscape: A comprehensive evaluation of the companies engaged in manufacturing of bioreactors and fermenters, based on several relevant parameters, such as [A] year of establishment, [B] company size, [C] region of headquarters, [D] geographical reach, [E] capacity, [F] scale of operation, [G] scalability, [H] type of bioprocess, [I] type of cell culture, [J] mode of operation and [K] type of end user.
• Company Competitiveness Analysis: A comprehensive competitive analysis of bioreactors and fermenter manufacturers, examining factors, such as [A] manufacturer strength and [B] portfolio strength.
• Company Profiles: In-depth profiles of key manufacturers engaged in the bioreactors and fermenter market, focusing on [A] overview of the company, [B] financial information (if available), [C] product portfolio, and [D] recent developments and [E] an informed future outlook.
• Capacity Analysis: An insightful analysis of the global installed bioreactors and fermenters capacity of biologics, based on several relevant parameters, such as [A] fabrication material, [B] target disease indication, [C] source of cell culture, [D] reactor volume, [E] type of manufacturer and [F] key geographical regions.
• Case Study: A detailed discussion on the market landscape of bioprocess controllers and automation systems, based on several parameters, such as [A] scale of operation, [B] key features, [C] compatibility with bioreactor system, [D] type of bioprocess and [E] type of process controlled. Additionally, a comprehensive evaluation of companies involved in the development of bioprocess control software, and upstream and downstream controllers, based on several relevant parameters, such as [A] year of establishment, [B] company size, and [C] location of headquarters.

KEY QUESTIONS ANSWERED IN THIS REPORT

• How many companies are currently engaged in this market?
• Which are the leading companies in this market?
• What factors are likely to influence the evolution of this market?
• What is the current and future market size?
• What is the CAGR of this market?
• How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

• The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
• Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
• The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

• Complimentary PPT Insights Packs
• Complimentary Excel Data Packs for all Analytical Modules in the Report
• 15% Free Content Customization
• Detailed Report Walkthrough Session with Research Team
• Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

1. PREFACE

• 1.1. Introduction
• 1.2. Key Market Insights
• 1.3. Scope of the Report
• 1.4. Research Methodology
• 1.5. Frequently Asked Questions
• 1.6. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

• 3.1. Chapter Overview
• 3.2. Overview of Bioreactors
• 3.3. Components of a Bioreactor
• 3.4. Types of Bioreactors
  • 3.4.1. Classification based on Type of Bioprocess
  • 3.4.2. Classification based on Mode of Action
• 3.5. Applications of Bioreactors
• 3.6. Future Perspectives

4. FERMENTER AND BIOREACTOR MANUFACTURERS: MARKET LANDSCAPE

• 4.1. Chapter Overview
• 4.2. Fermenter and Bioreactor Manufacturers: Overall Market Landscape
  • 4.2.1. Analysis by Year of Establishment
  • 4.2.2. Analysis by Company Size
  • 4.2.3. Analysis by Region of Headquarters
  • 4.2.4. Analysis by Location of Headquarters
  • 4.2.5. Analysis by Year of Establishment and Region of Headquarters
  • 4.2.6. Analysis by Company Size and Region of Headquarters
  • 4.2.7. Analysis by Year of Establishment, Company Size and Region of Headquarters
  • 4.2.8. Analysis by Geographical Reach
  • 4.2.9. Analysis by Region of Headquarters and Geographical Reach
  • 4.2.10. Analysis by Type of Product
  • 4.2.11. Analysis by Capacity
  • 4.2.12. Analysis by Scale of Operation
  • 4.2.13. Analysis by Scalability
  • 4.2.14. Analysis by Type of Bioprocess
  • 4.2.15. Analysis by Type of Cell Culture
  • 4.2.16. Analysis by Mode of Operation
  • 4.2.17. Analysis by Type of End-user

5. COMPANY COMPETITIVENESS ANALYSIS

• 5.1. Chapter Overview
• 5.2. Assumptions / Key Parameters
• 5.3. Methodology
• 5.4. Company Competitiveness Analysis: Small Companies
  • 5.4.1. Company Competitiveness Analysis: Small Companies based in North America
  • 5.4.2. Company Competitiveness Analysis: Small Companies based in Europe
  • 5.4.3. Company Competitiveness Analysis: Small Companies based in Asia-Pacific and Rest of the World
• 5.5. Company Competitiveness Analysis: Mid-sized Companies
  • 5.5.1. Company Competitiveness Analysis: Mid-sized Companies based in North America
  • 5.5.2. Company Competitiveness Analysis: Mid-sized Companies based in Europe
  • 5.5.3. Company Competitiveness Analysis: Mid-sized Companies based in Asia-Pacific and Rest of the World
• 5.6. Company Competitiveness Analysis: Large and Very Large Companies

6. COMPANY PROFILES

• 6.1. Chapter Overview
• 6.2. Applikon Biotechnology (acquired by Getinge)
  • 6.2.1. Company Overview
  • 6.2.2. Product Portfolio
  • 6.2.3. Recent Developments and Future Outlook
• 6.3. Bionet
  • 6.3.1. Company Overview
  • 6.3.2. Product Portfolio
  • 6.3.3. Recent Developments and Future Outlook
• 6.4. Cytiva
  • 6.4.1. Company Overview
  • 6.4.2. Financial Information
  • 6.4.3. Product Portfolio
  • 6.4.4. Recent Developments and Future Outlook
• 6.5. Eppendorf
  • 6.5.1. Company Overview
  • 6.5.2. Financial Information
  • 6.5.3. Product Portfolio
  • 6.5.4. Recent Developments and Future Outlook
• 6.6. Merck
  • 6.6.1. Company Overview
  • 6.6.2. Financial Information
  • 6.6.3. Product Portfolio
  • 6.6.4. Recent Developments and Future Outlook
• 6.7. Ollital Technology
  • 6.7.1. Company Overview
  • 6.7.2. Product Portfolio
  • 6.7.3. Recent Developments and Future Outlook
• 6.8. Parr Instrument Company
  • 6.8.1. Company Overview
  • 6.8.2. Product Portfolio
  • 6.8.3. Recent Developments and Future Outlook
• 6.9. Sartorius
  • 6.9.1. Company Overview
  • 6.9.2. Financial Information
  • 6.9.3. Product Portfolio
  • 6.9.4. Recent Developments and Future Outlook
• 6.10. Shanghai Bailun Biological Technology
  • 6.10.1. Company Overview
  • 6.10.2. Product Portfolio
  • 6.10.3. Recent Developments and Future Outlook
• 6.11. Solaris Biotech (acquired by Donaldson Company)
  • 6.11.1. Company Overview
  • 6.11.2. Product Portfolio
  • 6.11.3. Recent Developments and Future Outlook
• 6.12. Solida Biotech
  • 6.12.1. Company Overview
  • 6.12.2. Product Portfolio
  • 6.12.3. Recent Developments and Future Outlook
• 6.13. Zhengzhou Laboao Instrument Equipment (LABAO)
  • 6.13.1. Company Overview
  • 6.13.2. Product Portfolio
  • 6.13.3. Recent Developments and Future Outlook

7. CAPACITY ANALYSIS

• 7.1. Chapter Overview
• 7.2. Key Assumptions and Methodology
  • 7.2.1. Bioreactors and Fermenters: Global Installed Capacity of Biologics
    • 7.2.1.1. Analysis by Fabrication Material
    • 7.2.1.2. Analysis by Source of Cell Culture
    • 7.2.1.3. Analysis by Reactor Volume
    • 7.2.1.4. Analysis by Type of Manufacturer
    • 7.2.1.5. Analysis by Key Geographical Regions
• 7.3. Concluding Remarks

8. CASE STUDY: BIOPROCESS CONTROLLERS AND AUTOMATION SYSTEMS

• 8.1. Chapter Overview
• 8.2. Bioprocess Control Software: Overall Market Landscape
  • 8.2.1. Analysis by Scale of Operation
  • 8.2.2. Analysis by Key Features
  • 8.2.3. Analysis by Compatibility with System
  • 8.2.4. Analysis by Type of Process Controlled
• 8.3. Bioprocess Control Software Developers: Overall Market Landscape
  • 8.3.1. Analysis by Year of Establishment
  • 8.3.2. Analysis by Company Size
  • 8.3.3. Analysis by Location of Headquarters
• 8.4. Upstream Controllers: Overall Market Landscape
  • 8.4.1. Analysis by Scale of Operation
  • 8.4.2. Analysis by Key Features
  • 8.4.3. Analysis by Compatibility with Bioreactor System
  • 8.4.4. Analysis by Type of Bioprocess
  • 8.4.5. Analysis by Type of Process Controlled
• 8.5. Upstream Controller Developers: Overall Market Landscape
  • 8.5.1. Analysis by Year of Establishment
  • 8.5.2. Analysis by Company Size
  • 8.5.3. Analysis by Location of Headquarters
• 8.6. Downstream Controller Systems: Overall Market Landscape
  • 8.6.1. Analysis by Scale of Operation
  • 8.6.2. Analysis by Key Features
  • 8.6.3. Analysis by Type of System
  • 8.6.4. Analysis by Type of Bioprocess
  • 8.6.5. Analysis by Application Area
• 8.7. Downstream Controller System Developers: Overall Market Landscape
  • 8.7.1. Analysis by Year of Establishment
  • 8.7.2. Analysis by Company Size
  • 8.7.3. Analysis by Location of Headquarters

9. MARKET FORECAST

• 9.1. Chapter Overview
• 9.2. Key Assumptions and Forecast Methodology
• 9.3. Global Fermenters and Bioreactors Market, Till 2035
  • 9.3.1. Global Fermenters and Bioreactors Market, Till 2035: Distribution by Type of Product
    • 9.3.1.1. Global Bioreactors Market, Till 2035
    • 9.3.1.2. Global Fermenters Market, Till 2035
  • 9.3.2. Global Fermenters and Bioreactors Market, Till 2035: Distribution by Fabrication Material
    • 9.3.2.1. Global Glass Fermenters and Bioreactors Market, Till 2035
    • 9.3.2.2. Global Stainless Steel Fermenters and Bioreactors Market, Till 2035
    • 9.3.2.3. Global Single Use Fermenters and Bioreactors Market, Till 2035
  • 9.3.3. Global Fermenters and Bioreactors Market, Till 2035: Distribution by Type of Bioprocess
    • 9.3.3.1. Global Fermenters and Bioreactors Market for Batch and Fed-batch Process, Till 2035
    • 9.3.3.2. Global Fermenters and Bioreactors Market for Continuous Process, Till 2035
  • 9.3.4. Global Fermenters and Bioreactors Market, Till 2035: Distribution by Type of Biologic
    • 9.3.4.1. Global Fermenters and Bioreactors Market for Antibodies, Till 2035
    • 9.3.4.2. Global Fermenters and Bioreactors Market for Vaccines, Till 2035
    • 9.3.4.3. Global Fermenters and Bioreactors Market for Cell Therapies, Till 2035
    • 9.3.4.4. Global Fermenters and Bioreactors Market for Other Biologics, Till 2035
  • 9.3.5. Global Fermenters and Bioreactors Market, Till 2035: Distribution by Key Geographical Regions
    • 9.3.5.1. Global Fermenters and Bioreactors Market in North America, Till 2035
    • 9.3.5.2. Global Fermenters and Bioreactors Market in Europe, Till 2035
    • 9.3.5.3. Global Fermenters and Bioreactors Market in Asia-Pacific, Till 2035
    • 9.3.5.4. Global Fermenters and Bioreactors Market in Middle East and North Africa, Till 2035
    • 9.3.5.5. Global Fermenters and Bioreactors Market in Latin America, Till 2035

10. EXECUTIVE INSIGHTS

11. CONCLUDING REMARKS

12. APPENDIX 1: TABULATED DATA

13. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

관련자료